泰治疗outc - T1的未解决的问题ome definitions for nontuberculous mycobacterial pulmonary disease JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01636-2018 VL - 53 IS - 5 SP - 1801636 AU - Moon, Seong Mi AU - Jhun, Byung Woo AU - Daley, Charles L. AU - Koh, Won-Jung Y1 - 2019/05/01 UR - //www.qdcxjkg.com/content/53/5/1801636.abstract N2 - The incidence and prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing worldwide [1, 2]. NTM-PD treatment is challenging due to long-term, multiple antibiotic therapy and poor treatment outcomes [3, 4]. Standardised treatment outcome definitions for NTM-PD were recently reported in the Nontuberculous Mycobacteria Network European Trials Group (NTM-NET) consensus statement [5], and are an important development for patient management and clinical research [5].Evaluation of treatment outcomes after 6 months may be appropriate for NTM pulmonary disease (NTM-PD) patients. Patients with a single positive culture after culture conversion should be carefully followed up to detect recurrence of NTM-PD. http://ow.ly/JrSy30oj3uZ ER -